Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120443 · ClinicalTrials.gov registry record · NA
ivWatch Model 400: Device Validation for Non-Infiltrated Tissues
A NA study of Infiltration of Peripheral IV Therapy, sponsored by ivWatch.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT02120443 is a NA study of Infiltration of Peripheral IV Therapy that has completed, run by ivWatch. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02120443, a NA study of Infiltration of Peripheral IV Therapy, has completed, sponsored by ivWatch.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
A single arm study of 40 adult volunteers to assess the safety and efficacy of the ivWatch Model 400 when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.
Conditions Studied
Interventions
- DEVICE ivWatch Model 400
Study Locations (1)
Virginia
- ivWatch, LLC - Williamsburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02120443
The ClinicalTrials.gov registry entry for NCT02120443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ivWatch, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infiltration of Peripheral IV Therapy appearing as the primary indexed condition, and to 1 intervention - of which ivWatch Model 400 is the first listed.
NCT02120443 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT02120443 about?
NCT02120443 is a clinical study titled "ivWatch Model 400: Device Validation for Non-Infiltrated Tissues". A single arm study of 40 adult volunteers to assess the safety and efficacy of the ivWatch Model 400 when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.
What is the current status of trial NCT02120443?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-01. Estimated completion is 2014-01.
What conditions does trial NCT02120443 study?
This clinical trial studies the following conditions: Infiltration of Peripheral IV Therapy.
What interventions are being tested in trial NCT02120443?
The interventions under investigation include: ivWatch Model 400 (DEVICE).
Who is sponsoring clinical trial NCT02120443?
This trial is sponsored by ivWatch, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02120443 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infiltration of Peripheral IV Therapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.